The US home diagnostics for urinary tract infection market is expected to reach US$ 444.91 million by 2027 from US$ 267.44 million in 2019; it is expected to grow at a CAGR of 6.7% from 2020 to 2027.
Factors such as growing UTI prevalence and rising elderly population propel the growth of the market. However, inaccuracy in the results of home UTI screening tests is the major factor hindering the market growth.
Women are at a higher risk of developing urinary tract infections than men. These infections can lead to severe pain along with serious effects on kidneys, if left untreated. Urinary tract infections show certain symptoms such as persistent urge to urinate, inflammation, change in appearance of urine, and nausea. According to a study conducted by group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, urinary tract infections accounts for an estimated 6 million physician visits each year in the US. According to a study published by NCBI in 2019, urinary tract infections are the most commonly occurring infections among Americans. Additionally, according to the study, ~20% women over age 65 years in the US suffer from urinary tract infections each year. Further, the study concludes that ~50–60% of the adult women are expected to suffer from urinary tract infections at least once in lifetime across the globe. Factors such as sexual activity, poor hygiene, and aging are among the main causes of urinary tract infection. Increasing occurrence of these risk factors is also estimated to drive the home diagnostics for urinary tract infection market growth in the coming years.
In the US, the first confirmed case of COVID-19 infection was reported in January. The COVID-19 pandemic is likely to impact the home diagnostics for the urinary tract infection market growth significantly. The lockdown in the major cities of the countries has had severe impact on the US economies. The flow of trade has reduced dramatically and is likely to continue for the following few years. The focus of the market players has shifted toward the COVID-19 pandemic; therefore, demand for home diagnostics test kits is likely to drop down. However, various companies producing home diagnostics kits have channelized their efforts toward the production of COVID-19 diagnostics kits. For instance, in March 2020, US-based Scanwell Health and myLAB Box launched their latest products, at-home diagnostics services.
US Home Diagnostics for Urinary Tract Infection Market Revenue and Forecast to 2027 (US$ Million)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
US Home Diagnostics for Urinary Tract Infection Market – Market Segmentation
By Form Type
- Dipsticks
- Cup
- Dip slide
- Cassette
- Others
By Distribution Channel
- Retail Pharmacies &Drug Store
- Supermarket/Hypermarket
- Online Pharmacies
By Country
North America
- US
Company Profiles
- i-Health, Inc (AZO)
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Acon Laboratories, Inc.
- Becton Dickinson and Company
- Arkray Inc.
- Pathnostics
- Abbott Laboratories
- Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc)
- Teco Diagnostics
- Scanwell Health
US Home Diagnostics for Urinary Tract Infection Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 267.44 Million |
Market Size by 2027 | US$ 444.91 Million |
Global CAGR (2020 - 2027) | 6.7% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Form Type
|
Regions and Countries Covered | United State
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















The List of Companies - US Home Diagnostics for Urinary Tract Infection Market
- i-Health, Inc (AZO)
- F. Hoffmann-La Roche AG (Roche Holding AG)
- Acon Laboratories, Inc.
- Becton Dickinson and Company
- Arkray Inc.
- Pathnostics
- Abbott Laboratories
- Aytu BioScience, Inc. (Innovus Pharmaceuticals, Inc)
- Teco Diagnostics
- Scanwell Health


